Cargando…
Melatonin and Comorbidities in Children with Autism Spectrum Disorder
PURPOSE OF REVIEW: Melatonin is used to treat sleep difficulties associated with autism spectrum disorder (ASD). There are growing evidence that melatonin could have an effect on other symptoms than sleep, such as anxiety, depression, pain, and gastrointestinal dysfunctions. Interestingly, these sym...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096870/ https://www.ncbi.nlm.nih.gov/pubmed/30148039 http://dx.doi.org/10.1007/s40474-018-0147-0 |
_version_ | 1783348185086820352 |
---|---|
author | Gagnon, Katia Godbout, Roger |
author_facet | Gagnon, Katia Godbout, Roger |
author_sort | Gagnon, Katia |
collection | PubMed |
description | PURPOSE OF REVIEW: Melatonin is used to treat sleep difficulties associated with autism spectrum disorder (ASD). There are growing evidence that melatonin could have an effect on other symptoms than sleep, such as anxiety, depression, pain, and gastrointestinal dysfunctions. Interestingly, these symptoms frequently are found as comorbid conditions in individuals with ASD. We aimed to highlight the potential effect of melatonin on these symptoms. RECENT FINDINGS: Animal and human studies show that melatonin reduces anxiety. Regarding the effect of melatonin on pain, animal studies are promising, but results remain heterogeneous in humans. Both animal and human studies have found that melatonin can have a positive effect on gastrointestinal dysfunction. SUMMARY: Melatonin has the potential to act on a wide variety of symptoms associated with ASD. However, other than sleep difficulties, no studies exist on melatonin as a treatment for ASD comorbid conditions. Such investigations should be on the research agenda because melatonin could improve a multitude of ASD comorbidities and, consequently, improve well-being. |
format | Online Article Text |
id | pubmed-6096870 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-60968702018-08-24 Melatonin and Comorbidities in Children with Autism Spectrum Disorder Gagnon, Katia Godbout, Roger Curr Dev Disord Rep Autism Spectrum (A Richdale and L Lawson, Section Editors) PURPOSE OF REVIEW: Melatonin is used to treat sleep difficulties associated with autism spectrum disorder (ASD). There are growing evidence that melatonin could have an effect on other symptoms than sleep, such as anxiety, depression, pain, and gastrointestinal dysfunctions. Interestingly, these symptoms frequently are found as comorbid conditions in individuals with ASD. We aimed to highlight the potential effect of melatonin on these symptoms. RECENT FINDINGS: Animal and human studies show that melatonin reduces anxiety. Regarding the effect of melatonin on pain, animal studies are promising, but results remain heterogeneous in humans. Both animal and human studies have found that melatonin can have a positive effect on gastrointestinal dysfunction. SUMMARY: Melatonin has the potential to act on a wide variety of symptoms associated with ASD. However, other than sleep difficulties, no studies exist on melatonin as a treatment for ASD comorbid conditions. Such investigations should be on the research agenda because melatonin could improve a multitude of ASD comorbidities and, consequently, improve well-being. Springer International Publishing 2018-08-09 2018 /pmc/articles/PMC6096870/ /pubmed/30148039 http://dx.doi.org/10.1007/s40474-018-0147-0 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Autism Spectrum (A Richdale and L Lawson, Section Editors) Gagnon, Katia Godbout, Roger Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title | Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title_full | Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title_fullStr | Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title_full_unstemmed | Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title_short | Melatonin and Comorbidities in Children with Autism Spectrum Disorder |
title_sort | melatonin and comorbidities in children with autism spectrum disorder |
topic | Autism Spectrum (A Richdale and L Lawson, Section Editors) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096870/ https://www.ncbi.nlm.nih.gov/pubmed/30148039 http://dx.doi.org/10.1007/s40474-018-0147-0 |
work_keys_str_mv | AT gagnonkatia melatoninandcomorbiditiesinchildrenwithautismspectrumdisorder AT godboutroger melatoninandcomorbiditiesinchildrenwithautismspectrumdisorder |